Literature DB >> 18164211

Expression and purification of cysteine introduced recombinant saporin.

Emine Günhan1, Mimi Swe, Mine Palazoglu, John C Voss, Leo M Chalupa.   

Abstract

Saporin, a ribosome inactivating protein is widely used for immunotoxin construction. Here we describe a mutation of saporin (sap)-3 DNA by introducing a cysteine residue, followed by protein expression and purification by ion exchange chromatography. The purified Cys255sap-3, sap-3 isomer and commercially purchased saporin, were tested for toxicity using assays measuring inhibition for protein synthesis. The IC(50) values showed that the toxicity of the Cys255sap-3 is equivalent to the sap-3 isomer and commercial saporin. Reactivity of Cys255sap-3 was confirmed by labeling with a thio-specific fluorescent probe as well as conjugation with a nonspecific mouse IgG. We have found that a single cysteine within saporin provides a method for antibody conjugation that ensures a uniform and reproducible modification of a saporin variant retaining high activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164211      PMCID: PMC2719709          DOI: 10.1016/j.pep.2007.11.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  32 in total

1.  The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome.

Authors:  C Savino; L Federici; R Ippoliti; E Lendaro; D Tsernoglou
Journal:  FEBS Lett       Date:  2000-03-31       Impact factor: 4.124

2.  RIBOSOME-INACTIVATING PROTEINS: A Plant Perspective.

Authors:  Kirsten Nielsen; Rebecca S Boston
Journal:  Annu Rev Plant Physiol Plant Mol Biol       Date:  2001-06

3.  Acute effects of the skeletal muscle-specific immunotoxin ricin-mAb 35 on extraocular muscles of rabbits.

Authors:  S P Christiansen; A Sandnas; R Prill; R J Youle; L K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

4.  The amino acid sequence of a ribosome-inactivating protein from Saponaria officinalis seeds.

Authors:  B Maras; R Ippoliti; E De Luca; E Lendaro; A Bellelli; D Barra; F Bossa; M Brunori
Journal:  Biochem Int       Date:  1990-08

5.  Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.

Authors:  G Bergamaschi; V Perfetti; L Tonon; A Novella; C Lucotti; M Danova; M J Glennie; G Merlini; M Cazzola
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

Review 6.  Immunotoxins containing single-chain ribosome-inactivating proteins.

Authors:  J M Lambert; W A Blättler; G D McIntyre; V S Goldmacher; C F Scott
Journal:  Cancer Treat Res       Date:  1988

7.  The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli.

Authors:  I Barthelemy; D Martineau; M Ong; R Matsunami; N Ling; L Benatti; U Cavallaro; M Soria; D A Lappi
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells.

Authors:  K Eiklid; S Olsnes; A Pihl
Journal:  Exp Cell Res       Date:  1980-04       Impact factor: 3.905

9.  Expression and characterisation in E. coli of mutant forms of saporin.

Authors:  Eugenia Pittaluga; Anna Poma; Adele Tucci; Laura Spanò
Journal:  J Biotechnol       Date:  2005-04-09       Impact factor: 3.307

Review 10.  Immunotoxins: magic bullets or misguided missiles?

Authors:  E S Vitetta; P E Thorpe; J W Uhr
Journal:  Immunol Today       Date:  1993-06
View more
  3 in total

1.  Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

Authors:  Hongling Yuan; Quan Du; Matthew B Sturm; Vern L Schramm
Journal:  Biochemistry       Date:  2015-07-14       Impact factor: 3.162

2.  Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells.

Authors:  Lucia Salvioni; Filippo Testa; Linda Barbieri; Marco Giustra; Jessica Armida Bertolini; Giulia Tomaino; Paolo Tortora; Davide Prosperi; Miriam Colombo
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

3.  Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.

Authors:  Athena L Russell; Chengyu Prince; Taran S Lundgren; Kristopher A Knight; Gabriela Denning; Jordan S Alexander; Jaquelyn T Zoine; H Trent Spencer; Shanmuganathan Chandrakasan; Christopher B Doering
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-05       Impact factor: 6.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.